BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Retina
,
Alcohol
,
Rosiglitazone
,
rs2230926
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BACH1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Basophil of peripheral blood
Leukocyte (polymorphonuclear) of peripheral blood
Neutrophil of bone marrow
Eosinophil of peripheral blood
Mononuclear cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Platelet count below reference range
Platelet disorder
Blood coagulation disorder
Anemia
Viral enteritis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
modafinil
Nevirapine
Amanitins
meclocycline
MIRN203 microRNA, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
HR
FAM198B
SERPINF1
BACH1
CECR2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Prognostic Worth of Nrf2/BACH1/HO-1 Protein Expression in the Development of Breast Cancer.
LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1…
Role of BACH1 in multiple myeloma.
Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the In…
The electrophilic character of quinones is essential for the suppression of Bach1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001…
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune…
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ